Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?

Vista sencilla de ítem
dc.contributor.authorGamboa, Soledad Urra
dc.contributor.authorFischer, Martin C.
dc.contributor.authorMartínez, José R.
dc.contributor.authorVéliz, Loreto
dc.contributor.authorOrellana, Paulina
dc.contributor.authorSolar, Antonieta
dc.contributor.authorBohmwald, Karen
dc.contributor.authorKalergis, Alexis
dc.contributor.authorRiedel, Claudia
dc.contributor.authorCorvalán, Alejandro H.
dc.contributor.authorRoa, Juan C.
dc.contributor.authorFuentealba, Rodrigo
dc.contributor.authorCáceres, C. Joaquín
dc.contributor.authorLópez-Lastra, Marcelo
dc.contributor.authorLeón, Augusto
dc.contributor.authorDroppelmann, Nicolás
dc.contributor.authorGonzález, Hernán E.
dc.date.accessioned2022-10-17T22:46:04Z
dc.date.available2022-10-17T22:46:04Z
dc.date.issued2018
dc.descriptionIndexación Scopuses
dc.description.abstractPapillary thyroid cancer (PTC) is the most prevalent endocrine neoplasia. The increased incidence of PTC in patients with thyroiditis and the frequent immune infiltrate found in PTC suggest that inflammation might be a risk factor for PTC development. The CXCR3-ligand system is involved in thyroid inflammation and CXCR3 has been found upregulated in many tumors, suggesting its pro-tumorigenic role under the inflammatory microenvironment. CXCR3 ligands (CXCL4, CXCL9, CXCL10 and CXCL11) trigger antagonistic responses partly due to the presence of two splice variants, CXCR3A and CXCR3B. Whereas CXCR3A promotes cell proliferation, CXCR3B induces apoptosis. However, the relation between CXCR3 variant expression with chronic inflammation and PTC development remains unknown. Here, we characterized the expression pattern of CXCR3 variants and their ligands in benign tumors and PTC. We found that CXCR3A and CXCL10 mRNA levels were increased in non-metastatic PTC when compared to non-neoplastic tissue. This increment was also observed in a PTC epithelial cell line (TPC-1). Although elevated protein levels of both isoforms were detected in benign and malignant tumors, the CXCR3A expression remained greater than CXCR3B and promoted proliferation in Nthy-ori-3-1 cells. In non-metastatic PTC, inflammation was conditioning for the CXCR3 ligands increased availability. Consistently, CXCL10 was strongly induced by interferon gamma in normal and tumor thyrocytes. Our results suggest that persistent inflammation upregulates CXCL10 expression favoring tumor development via enhanced CXCR3A-CXCL10 signaling. These findings may help to further understand the contribution of inflammation as a risk factor in PTC development and set the basis for potential therapeutic studies.es
dc.description.urihttps://www.oncotarget.com/article/23502/text/
dc.identifier.citationOncotarget Volume 9, Issue 2, Pages 2445 - 2467 2018es
dc.identifier.doi10.18632/oncotarget.23502
dc.identifier.issn19492553
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/24318
dc.language.isoenes
dc.publisherImpact Journals LLCes
dc.subjectCancer Celles
dc.subjectCXCR2 Receptores
dc.subjectInterleukin-8es
dc.subjectChemokine receptorses
dc.subjectInflammationes
dc.subjectPapillary thyroid canceres
dc.titleDifferential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?es
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Urra_S_Differential_2018.pdf
Tamaño:
4.32 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
FM - Artículos de Revista